blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3925622

EP3925622 - COMBINATION THERAPIES [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  28.10.2022
Database last updated on 05.10.2024
FormerThe application has been published
Status updated on  19.11.2021
Most recent event   Tooltip28.10.2022Application deemed to be withdrawnpublished on 30.11.2022  [2022/48]
Applicant(s)For all designated states
Novartis AG
Lichtstrasse 35
4056 Basel / CH
[2021/51]
Inventor(s)01 / LEBWOHL, David
East Hanover, New Jersey 07936 / US
02 / PETERS, Malte
80469 Munchen / DE
 [2021/51]
Representative(s)Elkington and Fife LLP
Prospect House
8 Pembroke Road
Sevenoaks, Kent TN13 1XR / GB
[2021/51]
Application number, filing date21166347.111.09.2015
[2021/51]
Priority number, dateUS201462050116P13.09.2014         Original published format: US 201462050116 P
US201462059788P03.10.2014         Original published format: US 201462059788 P
US201562119060P20.02.2015         Original published format: US 201562119060 P
US201562199030P30.07.2015         Original published format: US 201562199030 P
[2021/51]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3925622
Date:22.12.2021
Language:EN
[2021/51]
Search report(s)(Supplementary) European search report - dispatched on:EP09.11.2021
ClassificationIPC:A61K39/395, A61K31/506, A61P35/00, C07K16/28
[2021/51]
CPC:
A61K31/506 (EP,CN,KR,US); A61K31/495 (RU); A61K39/39558 (CN,KR,US);
A61K31/55 (US); A61K39/395 (RU); A61K9/0053 (US);
A61P35/00 (EP,RU); A61P35/02 (EP); A61P43/00 (EP);
C07K16/28 (US); C07K16/2803 (US); C07K16/2818 (EP,CN,KR,US);
C07K16/2827 (US); C07K16/3023 (US); A61K2039/505 (EP,CN,KR,US);
A61K2039/54 (US); A61K2039/542 (US); A61K2039/545 (CN,US);
A61K2300/00 (KR); C07K2317/21 (US); C07K2317/73 (CN,KR);
C07K2317/76 (EP,US) (-)
C-Set:
A61K31/506, A61K2300/00 (US,CN,EP);
A61K39/39558, A61K2300/00 (CN,EP,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/51]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:KOMBINATIONSTHERAPIEN[2021/51]
English:COMBINATION THERAPIES[2021/51]
French:POLYTHÉRAPIES[2021/51]
Examination procedure23.06.2022Application deemed to be withdrawn, date of legal effect  [2022/48]
13.07.2022Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time  [2022/48]
Parent application(s)   TooltipEP15767683.4  / EP3191097
EP19199437.5  / EP3659621
Fees paidRenewal fee
31.03.2021Renewal fee patent year 03
31.03.2021Renewal fee patent year 04
31.03.2021Renewal fee patent year 05
31.03.2021Renewal fee patent year 06
12.09.2021Renewal fee patent year 07
26.08.2022Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]WO2011159877  (BRIGHAM & WOMENS HOSPITAL [US], et al);
 [I]WO2013019906  (GENENTECH INC [US], et al);
by applicantFR901228
 US2779780
 EP0125023
 EP0171496
 EP0173494
 WO8601533
 EP0184187
 GB2188638
 US4816567
 WO9002809
 EP0388151
 WO9100906
 WO9110741
 WO9117271
 WO9201047
 WO9203918
 WO9203917
 WO9209690
 WO9215679
 WO9218619
 WO9220791
 EP0519596
 WO9301288
 US5208020
 US5223409
 US5225539
 WO9404678
 WO9410202
 US5475092
 WO9630046
 US5585089
 US5585499
 US5624821
 US5648260
 US5693761
 US5693762
 US5811097
 WO9845332
 US5846545
 WO9920758
 WO9940196
 WO9952552
 US6054297
 WO0035436
 US6111090
 WO0103720
 WO0206213
 EP0666868
 WO02066470
 US6582959
 WO03064383
 WO03076424
 WO03077914
 US2003190317
 US2003203409
 US2003206899
 WO2004005281
 US6689607
 US6703020
 US2004047858
 WO2004060319
 US6780996
 WO2005007190
 WO2005012359
 US6884879
 WO2005044853
 US2005112126
 WO2005055808
 US2005186208
 WO2005113556
 WO2005115451
 WO2005121142
 US2006009360
 WO2006028958
 US7025962
 US7060269
 WO2006083289
 US7132255
 WO2006121168
 WO2006122806
 WO2007005874
 WO2007004415
 US7169791
 WO2007014011
 WO2007084786
 WO2007133822
 EP1866339
 WO2008024725
 EP0920505
 WO2008073687
 WO2009036082
 WO2009055730
 WO2009085983
 WO2009101611
 EP2099447
 WO2009114335
 WO2009114870
 US7618632
 WO2010003118
 WO2010006086
 US2010028330
 WO2010019570
 WO2010027827
 WO2010029082
 WO2010036380
 WO2010077634
 US7767675
 US7812135
 WO2010125571
 WO2011025927
 WO2011028683
 WO2011051726
 US7943743
 WO2011066342
 US2011150892
 WO2011090754
 US8008449
 US8039479
 WO2011155607
 US2012039906
 US2012114649
 WO2012079000
 WO2012177624
 US8354509
 WO2013019906
 US8388967
 WO2013039954
 US8415355
 EP2581113
 WO2013054331
 WO2013079174
 WO2013082366
 EP1947183
 US8501758
 US8552156
 US8552002
 US8586023
 US8591886
 WO2013179174
 WO2013184757
 US8609089
 WO2014008218
 WO2014012479
 WO2014022332
 US2014044728
 US2014072566
 US8685980
 WO2014059251
 US8709424
 US2014271618
 WO2015026684
 WO1986US02269
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.